The pathogenesis of glucocorticoid-induced osteoporosis

Clinical and Experimental Rheumatology

Volumn 18, Issue 5 SUPPL. 21, 2000, Pages

  Weinstein, R S ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Apoptosis; Bone cells; Glucocorticoids; Osteonecrosis; Osteoporosis

Indexed keywords

CALCIUM; GLUCOCORTICOID; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN BAX; PROTEIN BCL 2; SOMATOMEDIN;

APOPTOSIS; BONE ATROPHY; BONE DEVELOPMENT; BONE NECROSIS; CALCIUM ABSORPTION; HUMAN; HYPERPARATHYROIDISM; INTESTINE ABSORPTION; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOCYTE; OSTEOPOROSIS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SAFETY; STEROID THERAPY; TUMOR SUPPRESSOR GENE;

EID: 0033773177     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism)
2. Glucocorticoid-induced osteoporosis
3. Pathogenesis and treatment of steroid osteoporosis
4. Bone loss in response to long-term glucocorticoid therapy
5. Clinical and basic aspects of glucocorticoid action in bone
6. Nontraumatic necrosis of bone (osteonecrosis)
7. Preventing glucocorticoid-induced osteoporosis
8. Effects of short term glucocorticoid administration on intestinal calcium absorption and circulating vitamin D metabolite concentrations in man
9. Intact parathyroid hormone levels are not elevated in glucocorticoid-treated subjects
10. The course of biochemical parameters of bone turnover during treatment with corticosteroids
11. 1998 Corticosteroid-induced bone loss in men
12. Histomorphometric profile, pathophysiology and reversibility of corticosteroid-induced osteoporosis
13. Mean wall thickness and formation periods of trabecular bone packets in corticosteroid-induced osteoporosis
14. A prospective: Bone histomorphometry in glucocorticoid-induced osteoporosis
15. 1,25-Dihydroxyvitamin D3 modulates glucocorticoid-induced alteration in serum bone GLA protein and bone histomorphometry
16. Osteoblast programmed cell death (apoptosis): Modulation by growth factors and cytokines
17. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids: Potential mechanisms of the deleterious effects on bone
18. Linkage of decreased bone mass with impaired osteoblastogenesis in a routine model of accelerated senescence
19. Increased bone formation by prevention of osteoblast apoptosis with PTH
20. Perspective: New developments in the pathogenesis and treatment of steroid-induced osteoporosis
21. Apoptosis and osteoporosis
22. Early bisphosphonate treatment prevents long term adverse effects of glucocorticoid-induced osteoporosis in mice
23. Osteoprotegerin mRNA is expressed in primary human osteoblast-like cells: Down-regulation by glucocorticoids
24. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
25. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption
26. Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip
27. Insulin-like growth factors and their binding proteins: Biological actions
28. 1999 Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPARγ2
29. Reduction in transforming growth factor beta receptor I expression and transcription factor Cbfa1 on bone cells by glucocorticoids
30. Glucocorticoids induce adipogenesis of stromal cells by transcriptionally activating PPARγ2
31. Overexpression of Bcl-2 renders osteoblastic cells refractory to glucocorticoid-induced apoptosis
32. Reversal phase and osteopenia: Defective coupling of resorption to formation in the pathogenesis of osteoporosis